tm logo
LEQSELVI SUPPORT
FORMALIZED

on 11 Nov 2024

Last Applicant/ Owned by

Sun Pharmaceutical Industries, Inc.

2 Independence WayPrinceton, NJ 08540

US

Serial Number

2361352 filed on 11th Nov 2024

LEQSELVI SUPPORT

Trademark usage description

business administration of pharmacy reimbursement programs and services; retail pharmacy services; mail order pharmacy services; online retail pharmac Read More

Classification Information


Class [035]
Business administration of pharmacy reimbursement programs and services; retail pharmacy services; mail order pharmacy services; online retail pharmacy services; pharmaceutical services, namely, processing online and telephone prescription orders in retail and central fill pharmacies


Classification kind code

12

Class [036]
Patient benefits programs in connection with pharmaceutical services, namely, providing financial assistance for disadvantaged persons for pharmaceuticals; Financial administration of pharmacy reimbursement programs and services; Patient support and assistance in connection with pharmaceutical services, namely, providing information about eligibility for financial assistance provided through patient benefits programs; Insurance services in the form of insurance verification services and prior authorization services, namely, verifying Medicaid, Medicare, and commercial insurance eligibility status and related information for others


Classification kind code

12

Class [039]
Distribution services, namely, delivery of pharmaceutical products.


Classification kind code

12

Class [044]
Patient support and assistance in connection with pharmaceutical services, namely, providing medical information about pharmaceuticals


Classification kind code

12

Mark Details


Serial Number

2361352

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 287
on 21st Nov 2024
Pre-Assessment Letter Sent
Submitted for opposition 30
on 11th Nov 2024
Filed
Submitted for opposition 1
on 11th Nov 2024
Created
Submitted for opposition 31
on 11th Nov 2024
Formalized